|
Volumn 50, Issue 2, 2001, Pages 144-147
|
Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor
a,d b b c c |
Author keywords
Polymorphism; Schizophrenia; Serotonin receptor gene; Tardive dyskinesia
|
Indexed keywords
CHLORPROMAZINE;
NEUROLEPTIC AGENT;
SEROTONIN 2A RECEPTOR;
ADULT;
AGE;
ARTICLE;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
GENE FREQUENCY;
GENETIC RISK;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
GENOTYPE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
ANTIPSYCHOTIC AGENTS;
DOPAMINE;
DYSKINESIAS;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
GENOTYPE;
HUMANS;
MALE;
MIDDLE AGED;
POLYMORPHISM, GENETIC;
RECEPTORS, SEROTONIN;
RISK FACTORS;
SCHIZOPHRENIA;
SEROTONIN;
|
EID: 0035878579
PISSN: 00063223
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-3223(01)01076-9 Document Type: Article |
Times cited : (82)
|
References (39)
|